Name: Oluwayemi J. BAMIKOLE Designation: Research Fellow II Faculty: Clinical Sciences Department: Institute of Child Health Phone number: +234 7068505498 Email: This email address is being protected from spambots. You need JavaScript enabled to view it. Email Address 1: This email address is being protected from spambots. You need JavaScript enabled to view it. Email Address 2: This email address is being protected from spambots. You need JavaScript enabled to view it. Biography: Oluwayemi Joshua Bamikole is a Research Fellow II at the Institute of Child Health, College of Medicine, University of Ibadan, Nigeria, where he also serves as a doctoral candidate in Public Health Biotechnology. His research centers on Plasmodium falciparum malaria, antimalarial drug resistance, and the genetic determinants of host susceptibility, with a special focus on population genetics and the impact of Artemisinin-based Combination Therapy (ACT) in Nigeria. He earned his B.Sc. in Biochemistry from the University of Ilorin (2014) and an M.Sc. in Public Health Biotechnology from the University of Ibadan (2018), where he investigated interleukin-1 polymorphisms in relation to childhood malaria. He is currently advancing this line of work in his Ph.D. program, applying molecular epidemiology, bioinformatics, and statistical genetics approaches to malaria genomics. Bamikole is a fellow of the Public Health Design, Equity, Action, and Leadership (DEAL) program at the West African Institute of Public Health, a fellow of the Ife Institute of Advanced Studies, and a Fellow of the Nigeria Higher Education Academy. He also holds professional certification in Genetic Counselling in Sickle Cell Disease and has completed advanced trainings in bioinformatics, statistical genetics, human population genetics, and artificial intelligence/machine learning. His training has included programs organized by international institutions such as the University of London, University of Pittsburgh, Johns Hopkins University, and Northwestern University, as well as specialized courses by leading geneticists from the University of Michigan and the London School of Hygiene and Tropical Medicine. With a growing publication record, Bamikole has authored and co-authored papers in reputable journals including Pathogens and Global Health, Frontiers in Immunology, The American Journal of Tropical Medicine and Hygiene, Human Gene, and Springer Nature. He has also contributed sequence data to the National Center for Biotechnology Information (NCBI), USA. His research outputs span malaria genomics, host–parasite interactions, and drug resistance surveillance. He has presented his research at both national and international conferences. Notably, he delivered oral presentations at the European Molecular Biology Organisation (EMBO) Malaria Conference in New Delhi, India (2022), where he received the award for Most Energetic and Engaging Participant, the UI@75 International Innovation Conference (2024), and the 3rd Ibadan Public Health Conference (2024). In 2025, he was named a finalist in the Nigeria Malaria Modelling Fellowship (Cohort 5). Bamikole is an active member of six professional associations, including the American Society of Human Genetics (ASHG), African Society of Human Genetics (AfSHG), Africa Biogenome Project (AfricaBP), and the Nigerian Bioinformatics and Genomics Network (NBGN). He teaches genetics, bioinformatics, and advanced statistical methods to graduate students, supervises master’s research projects, and has contributed to the organization of scientific conferences such as the 3rd Ibadan Public Health Conference. Beyond academia, he is passionate about bridging research and practice. His long-term vision is to apply genomic insights and innovative technologies to strengthen malaria control, improve treatment outcomes, and advance public health in Nigeria and globally. Research in progress The population genetics of Plasmodium falciparum and Human Cytochrome p450 metabolising genes; the pressure on antimalaria drug resistance in Ibadan, Nigeria. Summary: It is expected that the study will show the genetic population structure of Plasmodium falciparum in Ibadan, the cytochrome p450 gene variations involved in metabolizing ACT drugs. A GIS mapping of Plasmodium falciparum population in Apete, Ibadan. Nigeria. Completed Research 1. Antibiotics as Antimalaria; Is there an emergence of Plasmodium falciparum drug resistance in Ibadan, south west Nigeria? 2. Genetic Variability of CYP2B6 Polymorphisms (785AG, 64CT & 516GT) in Southwest Nigerian Population: Implications for Malaria Treatment. 3. Association of Interleukin-1 (Il-1α and Il-1β) Polymorphism with Plasmodium falciparum Malaria Among Under Five Children in Ibadan, Nigeria. 4. Association of Nine Selected Toll Like Receptor Polymorphisms with Clinical Outcome of Malaria Among Children in Ibadan, Southwest Nigeria. 5. Effects of Alkaloids of Cocos Nucifera Husk fiber on Cardiovascular Disease Indices in Albino Mice. Cardiovasc Pharm Open Acess. 8:253. 6. Effects of Alkaloids of Cocos Nucifera Husk fiber on Some Selected Enzymes in the Albino Mice. Sequence submission to NCBI database Patents Chitosan Extraction Method Using Cockroach (Periplaneta Americana) Exoskeleton. F/PT/NC/2024/12757Profile
Research
Publications
Social Media Handle
Facebook: Profile Link
LinkedIn: Profile Link
Pinterest: Profile Link
Instagram: Profile Link
YouTube: Profile Link
Dr. Oluwayemi J. BAMIKOLE
Twitter: Profile Link